Besides other innovative stereotactic procedures (radiofrequency thermocoagulation, focused ultrasound, gamma knife) laser interstitial thermotherapy (LiTT) provides minimally invasive destruction of pathological soft tissues which could be especially relevant for epilepsy surgeries involving adult and pediatric patients. Unlike standard resections, no craniotomy is required; just a tiny borehole trepanation is sufficient. Damage to cortical areas when accessing deep lesions can be minimized or completely avoided, and treating epileptogenic foci near eloquent or even vital brain areas becomes possible. Here, we briefly describe the history and rationale of laser neurosurgery as well as the technical key features of the two currently available systems for magnetic resonance-guided LiTT (Visualase 1 , NeuroBlate 1 ; CE marks pending for both). We also discuss the published clinical experience with LiTT in the field of epilepsy surgery (approximately 200 cases) with regard to complications, LiTT-induced, long-term brain structural alterations, seizure outcome, preliminary neuropsychological findings and first estimates of treatment costs. Overall, the seizure outcome appears to be slightly worse than for resective surgery. Due to insufficient research methods (e.g. non-established measures, lack of a control condition), the expected neuropsychological superiority over resective surgery has not been unambiguously demonstrated thus far. Also, the cost-benefit ratio requires further critical evaluation. Clinical, multicenter and adequately controlled outcome studies of high quality should also accompany the imminent introduction of LiTT into the field of epilepsy surgery and therewith permit critical scientific evaluation and rational, individual, clinical decisions.
Introduction
Epilepsy surgery is a safe and effective form of treatment for therapy-resistant, symptomatic, focal epilepsies in adult and pediatric patients. Depending on the individual indication for surgery, long-term seizure freedom can be achieved in 50-60% of the patients [1, 2] . Epilepsy surgery inevitably requires a craniotomy and is also associated with other limitations. For example, targets located deep within the brain can only be reached by displacing or removing the overlying brain tissue and this can, in turn, strongly affect the postoperative outcome, (especially the cognitive outcome [3, 4] ). Furthermore, patients with multiple epileptogenic foci (e.g. in tuberous sclerosis) are frequently excluded from epilepsy surgery. In this regard, so-called stereotactic surgical procedures provide innovative solutions and represent a substantial extension of the neurosurgical toolbox. In this review, we focus on magnetic resonance (MR)-guided stereotactic laser thermocoagulation, also named laser interstitial thermotherapy (LiTT) or laser induced thermotherapy, and the published clinical experience with this innovative method in the field of epilepsy surgery.
Stereotactic destruction of pathogenic soft tissues
Stereotaxis (from the Greek word stereóz, meaning rigid or stiff, and tá jiz meaning arrangement, order) is a surgical procedure whereby the surgical target within the body is reached via minimally invasive means and is performed to a high degree of precision with a linear trajectory which was previously calculated using geometric methods (e.g. stereotactic frame, real-time imaging). As the brain parenchyma is insensitive to pain, stereotactic neurosurgery can generally be performed under local anesthesia and light sedation. Patients can usually be discharged after only a single night of intensive care monitoring. However, it should be noted that stereotactic procedures might be more time consuming than classical resections (e.g. [5] ).
As with cranial procedures, both tumor and epilepsy surgeries are presumed to be the major applications for stereotactic interventions. Two physical mechanisms of action are currently applied [6] [7] [8] :
Radio surgery (gamma knife, linear accelerators): radiation is applied in a focused manner and destroys the target tissue by ionization, i.e. production of ions and free radicals which destroy cells (i.e. radio necrosis) [9, 10] . Thermocoagulation (also known as thermotherapy, thermoablation): warmth (44 C-59 C) is applied in a focused manner and induces denaturation of tissue proteins. At temperatures of >60 C, vaporization or carbonization may be induced. Heating the tissue is achieved in three different physical ways: focused ultrasound (FUS) induces heat by absorption of the interspersed ultra sound [11, 12] ; stereotactic radiofrequency thermocoagulation (RFTC) induces heat by electrical current [13] [14] [15] ; and LiTT induces heat by absorption of interspersed laser light energy (i.e. photocoagulation) [16] . RFTC seems to use higher temperature (about 80 C) than LiTT (<60 ).
Both the RFTC and LiTT procedures require a tiny borehole trepanation (craniostomy) for inserting the guiding catheter (RFTC) or the laser applicator (LiTT), respectively. No hair must be removed and the wound can be closed with a single stitch. Neither the cranial radiosurgery nor the FUS procedure requires a craniostomy.
Of course, all stereotactic procedures and the calculation of the eligible linear trajectories (RFTC, LiTT) in particular, rely heavily on data obtained from magnetic resonance (MR) imaging. However, the term "MR-guided" should be reserved for those procedures in which (near) real-time MR monitoring is applied, be it MR thermometry or MR imaging. This type of MR guidance is only available for FUS and LiTT procedures. The RFTC equipment is not MR-compatible, however electrode placement can be monitored using (near) real-time fluoroscopy and computer tomography [17] .
In RFTC, the coagulation electrode can also be used as a depth electrode for 1-channel stereotactic EEG recordings along the defined trajectory. If necessary, additional thermolesions can be set at sites with salient electropathophysiological activity [18] [19] [20] . In LiTT, the SEEG recording along the defined trajectory was reportedly performed prior to inserting the laser applicator [21] . In contrast to FUS and gamma knife, RFTC and LiTT also allow for stereotactic biopsy and later histopathological characterization of the coagulated tissue [22] . However, in contrast to open surgery, it is no longer possible to carefully remove entire tissue blocks for subsequent electrophysiological examination of the still living neurons (e.g. patch clamp).
We will narrow our focus to LiTT; other stereotactic procedures and their respective applications in epilepsy surgery have been covered in recent reviews [10, 11, 13, 23, 24] .
Stereotactic laser thermocoagulation
In 1976, laser technology was first introduced to the neurosurgical community by the Austrian neurosurgeon, Fritz Heppner (1917 Heppner ( -2002 , at the University of Graz [25] . PubMed lists 19 of his papers on laser neurosurgery published from 1977 through 1988.
Heppner used CO 2 -gas lasers and, later on, Neodymium-doped Yttrium-Aluminum-Granat (Nd:YAG) solid state lasers [26] . Both of these lasers penetrate the tissue over short distances only and thereby allow very precise cutting in terms of tissue vaporization (i.e. disconnection, ablation) during open surgeries.
Using LiTT for the treatment of deeply embedded brain tumors was reportedly first proposed by a Japanese workgroup in 1986 [27] and then further developed in Tokyo (Japan) [28, 29] , Düsseldorf (Germany) [30, 31] , Berlin (Germany) [32] and Los Angeles (USA) [33] . In LiTT, a laser applicator, i.e. a sterile catheter with an embedded fiber optics and a laser diffusor tip (see [32] , Figs. 2 and 3) , is stereotactically guided towards the target under MRI or computer tomographic control. These groups used Nd:YAG lasers which have a specially constructed, light diffusing tip that prevents carbonization of the tissue (as carbonization would prevent beaming light through the tissue). The dosage and the resulting tissue heating were already monitored using MR thermometry (i.e. measurement of changing magnetic resonance frequencies of tissue water protons indicating warmth; [34] ). In light of these historical achievements, it might be more accurate to characterize the most recent developments in the field of laser neurosurgery as a technological renaissance [16] .
For disconnective procedures such as a callosotomy or ablation of larger hypothalamic hamartomas, several laser systems have reportedly been utilized as high-precision cutting instruments (e.g. CO 2 laser OmniGuide [35, 36] ; Thulium laser Revolix [37] ). However, for quasi-resective, cerebral, MR-guided LiTT, two systems are currently available: Visualase 1 (Medtronic) [38] and NeuroBlate 1 (Monteris) [39] . CE marking, i.e. European marketing approval, is pending for both systems (effective October 2016; Medtronic expects approval sometime after June 2017; personal communication, 18.1.2017; [40] ). Both systems use a surgical infrared diode laser (class 4) and, therefore, all those present in the operating theater must wear protective glasses. Wavelengths are selected in order to allow maximal light dispersal and heating of the target tissue (44-59 C). Light penetration of the tissue displays an improvement when compared to earlier laser technologies. For example, coagulating a metastasis of 2.5 cm intersection with a laser of 1064 nm wavelength (Nd:YAG laser) would take 73 min, whereas the same procedure can be completed in 6 min at a wavelength of 980 nm (diode laser) [41] . For both systems, the laser applicators are provided as sterile disposables. In contrast to earlier systems, the laser applicators are continuously cooled to avoid any collateral damage. Laser light is diffused from the applicator's light diffusing tip, however tissue vaporization or carbonization should still be avoided. The coagulated tissue volume has a cylindrical or ellipsoidal shape of several millimeters which intersects along the tip of the laser applicator (depending on the duration, intensity and direction of the interspersed laser light). Both systems use data obtained from system-compatible MR sequences (turbo spin echo) for high-resolution, (near) real-time MR thermometry. The interaction between structural MRI, MR thermometry, and the laser unit is organized by the workstation of the system which is equipped with the respective patented hardware and software. While laser applicator placement can take up to four hours, the coagulation procedure is performed within a few minutes [42] . Before performing an irreversible thermolesion, a harmless probe lesion is set at a low energy level (e.g. 3 W for 10-20 s; [43] ). This probe lesion can be detected via MR thermometry and facilitates the final monitoring of the correct laser applicator placement and all other settings. Prior to removing the stereotactic frame, the thermolesion is confirmed using MRI (FLAIR, T1).
In 1999, the Visualase 1 thermal therapy system was developed PhoTex diode laser. Room-temperature saline is applied in order to continuously cool the catheter. Depending on the laser energy, the maximum duration of use is 2 min. Beyond this time limit, there is an increased risk of melting the laser applicator and leaking cooling liquid. The laser applicator is "MR safe" up to 3 T; below the catheter, the system is "MR conditional". The applicator's external intersection is 1.65 mm. The laser light is symmetrically beamed into the tissue from the applicator's diffusing tip (length: 1 cm 
LiTT in epilepsy surgery
Cranial LiTT is primarily used in tumor surgery [47] , but cingulotomies for chronic pain were also performed [48, 49] . We reported the published clinical experience on LiTT in epilepsy surgery [6, 47, [50] [51] [52] [53] [54] . Searching PubMed with the search term "epilepsy AND laser", resulted in 340 entries, of which 58 are relevant (effective Oct 31st, 2016); two additional publications were added manually. One-third of these papers (22) are from the current year (2016) and another 17 papers are from the previous year. The earliest publications on LiTT in epilepsy surgery are from 1978 [55] , 1979 [56] and 1987 [57] and since 2012, additional papers have followed [38] . Of these, 43 papers report original data or case studies/series; 12 papers are reviews (some of which include embedded reports of their own clinical experience); and 5 papers are letters to the editor or comments. PubMed displayed 16 entries for the search term "Visualase", of which 14 were studies on cerebral applications (tumor/epilepsy surgery). For "NeuroBlate OR AutoLiTT", 6 papers were retrieved. One most recently published further paper was added during manuscript revision [58] .
In the following report, data was included from 226 patients who participated in group studies, case series and single case reports. For both systems, clinical studies on applications in the field of epilepsy surgery are scheduled and registered at clinicaltrials.gov 
Indications
With regard to epilepsy surgery, LiTT promises to be particularly feasible for the following indications (sorted in descending order according to number of publications): mesial temporal lobe epilepsy (mTLE), e.g. selective amygdalohippocampectomy (SAH) [5, 8, [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] , hypothalamic hamartoma (HH) [37, 46, [70] [71] [72] [73] [74] , complex and deep focal cortical dysplasias (FCD), including double cortex [54, [75] [76] [77] , nodular periventricual heterotopias (NPVH) [78, 79] , tuberous sclerosis (TS) and subependymal giant cell astrocytoma [80] , cavernoma/cavernous malformation (including surrounding hemosiderin ring) [81] .
If the patient does not achieve complete seizure freedom with LiTT, then the procedure can be repeated (several times), and an open resective surgery still remains a possibility. LiTT (targeting the deep, smaller portions of the malformation) was reportedly combined with open topectomy [77] or temporal lobe resection [60, 78] (targeting the larger near-surface portion of the malformation). In cases involving multiple potentially epileptogenic foci (e.g. in TS), LiTT can be applied sequentially in order to destroy the primary focus at a time. LiTT can also be used for disconnection, e.g. functional isolation of larger epileptogenic structures (e.g. NPVH [79] ) or callosotomy [35, 36, 82, 83] . To the best of our knowledge, LiTT has not yet been used in hemispherectomies/hemispherotomies.
Complications
Negative surgical outcomes can involve complications, which are defined as unexpected deviations from the normal (expected) course of surgery and postsurgical recovery [84] [85] [86] . Complications should be distinguished from failure-to-cure (i.e. unsatisfactory treatment outcomes; e.g. no effect on seizures) and sequelae (i.e. negative consequences which are inherent to the surgical procedure; e.g. visual field defect after SAH). In general neurosurgery, the complication rate is one out of every four cases [87] . However, the complication rates are far lower in resective epilepsy surgery (<5% complications, <2% chronic neurological harm, <1% mortality; [88] ). This is most likely due to the better preoperative status (i.e. elective treatment) and the lower average age of the patients.
Given the small sample sizes and the highly heterogeneous surgical indications, it is not yet possible to obtain a meaningful estimate of the complication rates for LiTT in epilepsy surgery or to even directly compare these rates against those for resective surgeries. Complication rates for LiTT in epilepsy surgery seem to be lower than for LiTT in tumor surgery [89] . Usually, LiTT patients can be discharged after one night of intensive care unit monitoring and they can return to work the following week (e.g. [5, 66] ). Compared to resective procedures, fewer analgesics are needed [5] . Postoperatively treating the patient with dexamethasone for a few days in order to prevent brain edema seems to be standard practice [5, 54] . In several group studies and case reports, no complications were cited [35, 42, 48, 76, 81, 90] . Several studies reported an absence of otherwise severe, frequently occurring complications (e.g. diabetes insipidus or memory disturbances after treatment of hypothalamic hamartomas; [73] ). Approved measures to reduce the rate of complications during LiTT have been proposed by Pruitt et al. [89] .
The following mild (i.e. easily controlled) and transient complications were reported in single cases (sorted in descending order according to the number of studies): hemorrhage/hematoma [66, 68, 70, 71, 73, 89] , ipsilateral motor weakness [46, 70, 71] , diplopia (damage to N. trochlearis) [66, 69] , headache [5, 66] , body weight loss/gain (after LiTT treatment of HH) [46, 71] , brain edema [66] , impaired emotional well-being [66] , insomnia [66] , allergic reaction to intraoperative fosphenytoin i.v. [38] , short-term memory disturbance [38] , stuttering and expressive dysphasia [70] , transient aphasia [22] , aseptic meningitis [5] , and only partially remitted homonymous hemianopsia [58] .
LiTT-specific complications were reported in several cases and included the initial misplacement of the catheter, the need for a replacement catheter [54, 70, 89] as well as a device malfunction (usually the cooling system) [54, 89] . In one case, catheter misplacement resulted in subarachnoidal and intraventricular bleeding in the Sylvian fissure region (complete remission was achieved by external lumbar liquor drainage over 14 days; [54] ) and chronic hemianopsia in another case [68] . In both cases, misplacement was recognized in time and no thermocoagulation was performed. In a third case, chronic quadrantanopia developed as a result of catheter misplacement [69] . Finally, in one patient, the laser diffusing tip was broken after the cooling system failed. The decision was then made to keep the broken tip in situ and no further complications have been reported [64] .
One very severe case of adverse side effects of LiTT involved persistent, severe amnestic syndrome after thermotherapy of HH [74] and another involved a patient with mTLE who committed suicide after LiTT was reported [66] . Of note, the latter patient was suicidal before surgery and LiTT was a treatment failure.
No mortalities have been reported.
Long-term structural brain alterations
Detecting LiTT-induced brain structural alterations partly depend on the applied MRI sequence [43, 91] . Neuroimaging follow-up for LiTT epilepsy surgery patients revealed an increasing loss of volume of the coagulated brain structure; hemorrhagic necrosis and blood products (methemoglobine) within the lesion (i.e. T1 signal hypointensities); a ring of reduced diffusion or T1 signal hypointensities in the treatment zone; pronounced T2 signal hyperintensities and increased gadolinium uptake at the edge of the treatment zone (indicating encephalomalacia); and perilesional edema which decrease over time [22, 42, 58, 81, 92] . Other studies reported increased FLAIR signal intensity (indicating gliosis) as well as cystic alterations in the region of the coagulated brain structure [38, 92] . A comprehensive review of long-term effects of LiTT was provided by Atsina et al. [92] .
Different than intended, LiTT does not completely destroy the target tissue [38, 68] ; the same holds true for RFTC, at least for application in the hippocampus [93] . Wu et al. [69] compared the volumes of irreversibly destroyed brain tissue during LiTT/SAH both before and after optimizing the stereotactic procedures. With the standard protocol, 52% AE 12% (range: 35-73%) of the hippocampus and 42% AE 28% (range: 0-79%) of the amygdala were destroyed, but with the optimized protocol (i.e. stronger orientation to individual anatomical landmarks), a slightly larger volume could be destroyed (no data were provided). Of note, it is still unclear whether the relative or absolute coagulated volume is correlated to the seizure outcome [68, 93] . Jermakowicz et al. [58] recently proposed that complete destruction of the hippocampal head might be the key to optimal seizure outcomes. The potential for equally precise and complete destruction of the pathogenic structures will probably be determined based on the future indications of stereotactic versus resective procedures.
Seizure outcome
It is not possible to obtain an overall estimation of the seizure outcome after LiTT (e.g. Engel classes or seizure freedom rate), nor can a direct comparison against resective surgeries be made. The seizure freedom rate strongly depends on the follow-up interval, the drop-out rate, and the (lacking) willingness to offer surgical therapies to patients who are "possible", but not "optimal", candidates. Unlike resective epilepsy surgery, it is possible to perform surgical procedures with LiTT at those sites that have targets located deep within the brain or close to eloquent and vital brain structures. However, the emerging overall picture indicates that the seizure outcome for LiTT appears good, but slightly worse than for resective surgeries (difference about 10-20%). The methods involved for reporting seizure outcomes do not always follow the established standard, i.e. Engel outcome classes, and some studies did not report seizure outcomes at all [42, 48, 63, 89] .
Mesial temporal lobe epilepsy
In a retrospective study, Drane et al. [62] compared the seizure outcomes after LiTT (n = 21) and individually tailored standard resections (n = 39). At the 6-month follow-up, 11 out of 21 LiTT patients, and 24 out of 39 standard resection patients were seizure free. In a similar study conducted in older patients (age >50 years; mean follow-up interval: 1.8 years), all standard resection patients (n = 7) experienced complete seizure freedom, while 4 out of 5 LiTT patients (with sufficient follow-up intervals) were seizure free and one patient still had seizures but showed good benefit. In two other patients, an evaluation was not yet possible due to the short follow-up interval. In a recent study (n = 23) 69% of the LiTT patients became free of disabling seizures (Engel classes IA-C, follow-up interval !12 months) [58] ; furthermore, 12 out of 14 patients were free of disabling seizures at the long-term follow-up (!24 months). Kang et al. [66] (n = 20 patients; 14 left, 6 right) reported seizure freedom after 6, 12 and 24 months in 8 out of 15 patients; 4 out of 11 patients; and 3 out of 5 patients, respectively. Those LiTT patients who were not seizure free displayed no improvement concerning their seizure status, except for one patient who presented the "running down" phenomenon, with seizure frequency decreasing over time after thermotherapy. In four patients, standard resections were performed after LiTT failure, and two of these patients became seizure free (follow-up was pending in the fourth patient). Willie et al. [68] reported seizure freedom in 7 out of 13 patients, and a clinically relevant improvement in three additional patients (follow-up interval: 5-26 months). They neither found a correlation between the volume or length of the coagulated brain structures and the seizure outcome, nor an effect of present versus absent hippocampal sclerosis on the seizure outcome. Wu et al. [69] reported seizure outcomes for 10 patients who underwent LiTT with the stereotactic standard program (i.e. pre-protocol). Four out of ten patients became seizure free; four further patients were free from disabling seizures (only auras); one patient experienced a clinically relevant improvement; and LiTT yielded no effect in one patient. Curry et al. [38] reported seizure freedom for both of their pediatric patients and Dredla et al. [63] obtained seizure freedom in their two MRI-negative (MRIÀ), but PET-positive (PET+), mTLE patients.
Hypothalamic hamartoma
Wilfong and Curry [73] reported seizure freedom for 12 out of 14 pediatric patients with HH (aged 22 months to 20 years; followup interval: 1-24 months). One of these patients required a second LiTT. In another small pediatric case series with mixed indications for surgery, one out of two children with HH became seizure free [38] . Another study reported freedom of gelastic and other types of seizures in 4 out of 6 children [70] (follow-up interval: >6 months); the 2 other patients experienced clinically relevant benefits. Both patients of Burrows et al. [71] achieved early seizure freedom, but one patient experienced a seizure relapse after 18 months. Lewis et al. [54] achieved no improvements in a single child with HH, while Brandmeir et al. [46] obtained seizure freedom in their single patient (follow-up: 6 months).
Nodular periventricular heterotopias
Esquenazi et al. [78] reported seizure freedom for both patients with NPVH after LiTT which was, however, combined with changes in pharmacotherapy for one patient and resective surgery in the other. Likewise,Thompson et al. [79] reported two cases of successful LiTT for NPVH.
Tuberous sclerosis
Curry et al. [38] reported seizure freedom for one child with TS, while Lewis et al. [54] reported seizure freedom in two out of four children and moderate improvements in another child.
Focal cortical malformations
Lewis et al. [54] reported seizure freedom in 5 out of 12 children, marked improvement in one child, and moderate improvement in another child (follow-up interval: 9.3-35.9 months). The malformations showed a diversity of histopathologies. Devine et al. [76] achieved seizure freedom in their single patient with FCD.
Cavernoma/cavernous malformations
In a small case series, 4 out of 5 patients became seizure free [81] (follow-up interval 12-28 months). Three of these seizure-free patients showed a single provoked event (aura, seizure) during a trial of antiepileptic drug withdrawal. The fifth patient became seizure free after extensive resective surgery.
Other indications
In one patient with an epileptogenic focus in the insular cortex, LiTT helped the patient achieve seizure freedom [22] . Hawasli et al. [90] also reported seizure freedom by means of an LiTT treatment of an insular focus in a post-stroke epilepsy patient (follow-up interval: 23 months). In a more methodological study, Tiwari et al. [43] reported seizure freedom for all four epilepsy patients (indications were not given).
Neuropsychological outcome
Because a superior cognitive outcome with LiTT might possibly compensate for the still good, but inferior, seizure outcome, neuropsychology will play an important role in identifying additional indications for LiTT versus resective surgery [60] . Taking this into account, the lack of valid and state-of-the-art neuropsychological evaluation studies is disappointing [94, 95] . Thus, no final judgment is possible in this important third area. The scheduled SLATE Study (Visualase © ) will actually be the first to apply established sensitive measures of verbal memory (i.e. the Rey Auditory Verbal Learning Test).
Mesial temporal lobe epilepsy
In their previously referenced study, Drane et al. [62] found individually significant deteriorations in confrontative naming (verbal task) and/or recognition of famous faces (nonverbal task) for 32 out of 39 patients who underwent tailored resective surgeries of temporal and mesiotemporal structures (including SAH) in their speech dominant or nondominant hemisphere, respectively. In contrast, none of their 19 LiTT patients (9 procedures in speech dominant hemisphere) showed individually significant post-procedure deteriorations in these tasks. This finding was independent of the seizure outcome and the absence versus presence of hippocampal sclerosis. In contrast, the most recent study found significant postsurgical decline of mean verbal memory performance (Wechsler Memory Scale-Revised, Logical Memory II) in those patients who underwent LiTT in their speech dominant hemisphere [58] ; no other significant pre-post effects were reported. On an individual level, significant performance declines and improvements were observed in several patients however with no clear material-dependent lateralization pattern. The cognitive outcome in this study showed no correlation with the LiTT procedure (e.g. ablation volumes, laser trajectories) or the seizure outcome. Waseem et al. [5] . reported markedly reduced intellectual performance (IQ) in 1 out of 7 LiTT patients; deterioration of verbal memory performance in 1 out of 3 tested patients; deterioration of naming and verbal fluency (semantic and phonematic) in 2 out of 4 patients; and no effect of LiTT on visuospatial functions. In contrast, none of their seven patients who underwent a resective surgery showed postsurgical cognitive decline, except one who displayed postsurgical reduced verbal fluency. On the group level, Kang et al. [66] found a statistically significant reduction in total immediate free recall (trials 1-5) of the California Verbal Learning Test (CVLT), but no effect on CVLT delayed recall or recall scores of the Logical Memory I and II subtests from the Wechsler Memory Scale. In 3 out of 6 patients, the CVLT total immediate free recall score reduction was individually significant (reliable change indices, 90% confidence intervals). Dredla et al. [63] found markedly reduced memory performance in their two MRIÀ/PET+ mTLE patients. Brandmeir et al. [46] observed cognitive improvements in their single patient, but provided no psychometric evidence.
Other indications
One post-stroke epilepsy patient who underwent LiTT for an epileptogenic focus in the insular cortex, experienced diverse, individually significant, deteriorations in cognitive, particularly verbal performance [90] .
As previously mentioned, aphasia [22] , stuttering and expressive dysphasia [70] and short-term memory disturbances [38] were reported as transient cognitive complications. One patient with HH experienced a severe chronic amnestic syndrome and deterioration of attentional functions due to LiTT (probably following unintended thermal lesioning of parts of the mamillary bodies) which improved, but finally persisted despite intensive rehabilitation training. [74] . As stated above, another patient with mTLE who was suicidal before the procedure committed suicide after LiTT failure [66] .
Costs
LiTT requires a long time to prepare and plan and this should not be ignored. Although an LiTT performed under local anesthesia seems possible, one will usually decide in favor of a narcosis with intubation [89] . Thus, it is not surprising that Waseem et al. [5] reported higher operating room costs for SAH via LiTT (n = 7; 89.759 AE 11.092 US-$) than for open standard anterior temporal lobe resection (n = 7; 63.991 AE 9.061 US-$). Despite shorter hospital stays, the overall costs for LiTT (119.818 AE 15.035 US-$) were also higher than for the standard resective procedure (98.471 AE12.840 US-$).
Conclusion and outlook
Stereotactic procedures and LiTT in particular are viewed as important instruments in the neurosurgical toolbox, but probably do not represent (nor are they intended to represent) an alternative to, or even replacement of, open resections. Seizure outcomes appear to be slightly worse than in standard epilepsy surgery and the expected superiority in terms of cognitive outcome has not as yet been proven. Despite markedly shorter hospital stays, the overall treatment costs for LiTT may be higher than for standard surgery, and the cost-benefit ratio needs careful consideration. However, stereotactic procedures might increase the general acceptance of epilepsy surgery which is still underutilized [96] , and many patients will appreciate having the option of a minimally invasive surgical treatment. In fact, one study reported that 13 out of 13 patients who were offered both surgical options preferred LiTT over standard resection [68] . Thus, European marketing approval for both systems would be highly valued. A recent Cochrane review expressed a harsh and embarrassing critique of the low methodological quality epilepsy surgery studies [97] . The imminent introduction of LiTT and other stereotactic procedures into the field of epilepsy surgery should therefore be accompanied by high quality and well-coordinated, multi-center, clinical research from the onset, and all contributors À including researchers, editors, and reviewers À should stick to the highest possible standards and utilize appropriate and valid study designs with adequate control conditions (e.g. historical pairwise matched controls), measures and statistics. In particular, data on presurgical neuroimaging [15] , complications, seizure outcome and neuropsychological outcome must be reported fully and in a standardized manner [94] .
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